Vigilant Biosciences, based in Miami, FL, is a pioneering company dedicated to revolutionizing early detection of oral cancer through their innovative BeVigilant OraFusion System. Their patented technology aims to aid clinicians in identifying specific biomarkers associated with oral cancer, ultimately improving survival outcomes by detecting the disease at its most treatable stages.
With a vision to become a global leader in early cancer detection, Vigilant Biosciences is committed to transforming the future of healthcare by saving lives and enhancing patient outcomes. Through advanced methodologies and a sense of urgency, they strive to make a significant impact in the fight against oral cancer worldwide.
Generated from the website